Adcentrx Therapeutics Announces Completion of $38 million Series A+ Financing Led by Eight Roads Ventures
January 13,2023
Please Join ABio-X CEO Jeff Jonas and various industry experts on Wednesday, January 18th, from 2 to 3 p.m. ET as we look at what’s to come for the biotech sector in 2023. Take a look at some of the questions we’ll be debating below:
Will pharmaceutical companies take a more active role in dealmaking?
What clinical trial readouts could shape R&D investments?
Adcentrx Therapeutics Announces Completion of $50M Series A Financing Led By CBC Group To Accelerate Next-Generation Conjugate Drugs Research & Development.
ENSEM Therapeutics is proud to announce our Series A funding of $67 million to further advance our Kinetic EnsembleTM platform and accelerate R&D pipeline.